Skip to main content
. Author manuscript; available in PMC: 2009 Dec 15.
Published in final edited form as: AIDS. 2008 Nov;22(18):2481–2492. doi: 10.1097/QAD.0b013e328318f130

Figure 2. Estimated AIDS free survival among 13,546 antiretroviral naïve HIV-infected patients in the Antiretroviral Therapy Cohort Collaboration (ART-CC) initiating ART with ZDV/3TC stratified by 3rd drug, 2000 – 2005.

Figure 2

Survival curves shown are estimated from a Weibull model with follow-up censored at 2 years, with covariates set at the average value across the population of patients and for the cohort with median survival. Corresponding adjusted hazard ratios are shown in Table 3.